Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupuytren's disease study
2013-001221-13Phase 4Completed
- Sponsor
- Akershus University Hospital
- Start
- Jul 2013
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of collagenase clostridium histolyticum in Dupuytren's contracture (2 arms), sponsored by Akershus University Hospital. Primary endpoint: Correction of contracture. Started Jul 2013; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2013-001221-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001221-13.